Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Fractional ID vs Full IM Booster of IMOVAX Polio in Toddlers
NCT00885157Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2009
- Primary completion
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of inactivated poliovirus vaccine in poliomyelitis, sponsored by Sanofi. Started Apr 2009; status: completed.
02
Drugs
inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT00885157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885157.